Katherine Takaki

Katherine Takaki, Ph.D. is the VP of Global Regulatory Affairs at Trevi. She has over 30 years of pharmaceutical industry experience in regulatory strategy, global project and team management, and drug discovery. Before joining Trevi, Katherine served as Vice President, Global Regulatory Affairs at Iterum Therapeutics where she helped build out the regulatory group to support the Company’s regulatory strategy and operations. Prior to that, she held leadership positions at Bristol Myers Squibb supporting multiple therapeutic areas and covering all stages of drug discovery and development. She was the global project manager for the team that developed Baraclude for the treatment of hepatitis B and launched it in markets worldwide. She was subsequently the Group Director, Head of Regulatory Strategy Marketed Products at Bristol Myers Squibb. Katherine holds a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology and a B.S. in Chemistry from the University of Hawaii at Manoa.